The weight loss seen when using semaglutide is greater than when using other classes of antiobesity medications: Orlistat (6%) Lorcaserin (6%) Phentermine-topiramate (8%-10%) Naltrexone-bupropion (5%) 5% to 10% of initial weight is defined as significant weight loss
JAMA 330(22):21402142
Provide a complete list of all medications, supplements, and herbal products you use Discuss your reasons for wanting to add inositol and whether it addresses unmet therapeutic needs Consider whether inositol is necessary given that Wegovy already addresses metabolic and weight management goals If you have diabetes, discuss potential glucose monitoring requirements If you have diabetic retinopathy, be aware that rapid improvements in glucose control with semaglutide may temporarily worsen this condition [16] [20] Wegovy should not be used during pregnancy or breastfeeding and should be discontinued at least two months before a planned pregnancy [1] [2] Monitoring recommendations if proceeding with both: Be vigilant for signs of hypoglycaemia (low blood sugar): shakiness, sweating, confusion, rapid heartbeat, dizziness
Common Side Effects and Safety Considerations Zevay's FAQ names nausea and fatigue as examples of possible side effects, but those examples aren't a complete safety profile
Many people wonder whether semaglutide is a short-term weight loss tool or a long-term solutionthe answer is both, depending on your health needs and how your body responds
If you experience any significant changes, such as unexpected weight loss or frequent low blood sugar episodes, speak with your doctor.
